Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

3.95
-0.0300-0.75%
Post-market: 3.93-0.0200-0.51%16:51 EDT
Volume:313.95K
Turnover:1.25M
Market Cap:304.60M
PE:-3.97
High:4.07
Open:4.02
Low:3.94
Close:3.98
Loading ...

US Equity Futures Higher as Trump Considers 80% China Tariffs

MT Newswires Live
·
09 May

Mizuho Securities Reaffirms Their Buy Rating on Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
09 May

Corvus Pharma Reports 'Favorable' Interim Phase 1 Results in Atopic Dermatitis Trial; Shares Surge Premarket

MT Newswires Live
·
09 May

Corvus Pharma Q1 EPS $(0.13) Misses $(0.12) Estimate

Benzinga
·
09 May

Corvus Pharmaceuticals Reports Q1 2025 Results: Net Income Surges to $15.2M, Driven by $25.1M Gain from Warrant Liability Adjustment

Reuters
·
09 May

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results

THOMSON REUTERS
·
09 May

Corvus Pharmaceuticals Inc Q1 Shr View $-0.12 -- Lseg Ibes Data

THOMSON REUTERS
·
09 May

Corvus Pharmaceuticals Inc: Qtrly Loss per Share $0.13

THOMSON REUTERS
·
09 May

Corvus Pharmaceuticals Announces Data From Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

THOMSON REUTERS
·
09 May

Corvus Pharmaceuticals Inc - Data Shows Favorable Safety and Efficacy Profile in Cohort 3

THOMSON REUTERS
·
09 May

Corvus Pharmaceuticals Inc - Soquelitinib Well Tolerated With No Dose Limiting Toxicities

THOMSON REUTERS
·
09 May

Corvus Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
07 May

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

GlobeNewswire
·
24 Apr

Is Corvus Pharmaceuticals, Inc. (CRVS) the Best Multibagger Penny Stock to Buy According to Billionaires?

Insider Monkey
·
23 Apr

BRIEF-Corvus Pharmaceuticals Appoints Richard A. Van Den Broek To Board Of Directors

Reuters
·
10 Apr

Corvus Pharmaceuticals Appoints New Director to Board

TIPRANKS
·
10 Apr

Corvus Pharmaceuticals Appoints Richard a. Van Den Broek to Board of Directors

THOMSON REUTERS
·
10 Apr

Press Release: Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors

Dow Jones
·
10 Apr

Corvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges

TIPRANKS
·
27 Mar

Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow Jones
·
27 Mar